Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Silence Therapeutics plc ADR

WKN: A2QB4J / Symbol: SLN / Name: Silence Therapeutics / Stock / Mid Cap /

€11.70
-0.850%

1 1
1
1
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial

Key Points

MarketBeat 
0 11.08.26
Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know
Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know

Silence Therapeutics PLC Sponsored ADR (SLN) closed the last trading session at $13.58, gaining 30% over the past four weeks, but there could be plenty of upside left in the stock if short-term

Zacks 
0 13.08.26